Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
RESEARCH TOOLSreports
Holding SUPN?
Track your performance easily
See the Price Targets and Ratings of:
SUPN Analyst Ratings
Moderate Buy
2 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SUPN Stock 12 Month Forecast
Average Price Target
$39.25
▲(3.75% Upside)
| Highest Price Target$43.00 | Average Price Target$39.25 | Lowest Price Target$36.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stifel Nicolaus
Reiterated
11/05/24
Piper Sandler
Reiterated
11/05/24
TD Cowen
Assigned
11/05/24
Jefferies
Reiterated
10/18/24
Best Analysts Covering Supernus Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy SUPN and Sell After:
1 Month
xxx
Success Rate
5/7 ratings generated profit
Average Return
+3.90%
assigned a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 71.43% of your transactions generating a profit, with an average return of +3.90% per trade.
3 Months
xxx
Success Rate
5/7 ratings generated profit
Average Return
+4.23%
assigned a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +4.23% per trade.
1 Year
2 Years
xxx
Success Rate
7/7 ratings generated profit
Average Return
+18.99%
assigned a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +18.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SUPN Analyst Recommendation Trends
Rating
May 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
2
1
1
0
0
Buy
7
7
4
4
3
Hold
2
2
2
3
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
10
7
7
8
Each month's total comprises the sum of three months' worth of ratings.
SUPN Financial Forecast
SUPN Stock Forecast FAQ
What is SUPN’s average 12-month price target, according to analysts?
Based on analyst ratings, Supernus Pharmaceuticals’s 12-month average price target is $39.25.
What is SUPN’s upside potential, based on the analysts’ average price target?
Supernus Pharmaceuticals has 3.75% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SUPN a Buy, Sell or Hold?
Supernus Pharmaceuticals has a consensus rating of Moderate Buy which is based on 2 buy ratings, 2 hold ratings and 0 sell ratings.
What is Supernus Pharmaceuticals’s price target?
The average price target for Supernus Pharmaceuticals is $39.25. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $43.00 ,the lowest forecast is $36.00. The average price target represents 3.75% Increase from the current price of $37.83.
The highest analyst price target is $43.00 ,the lowest forecast is $36.00. The average price target represents 3.75% Increase from the current price of $37.83.
What do analysts say about Supernus Pharmaceuticals?
Supernus Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of SUPN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.